The APM research program uses repurposed drugs (potentially disease modifying drugs that could slow or stop Parkinson’s progression), integrated with genomics research. The APM aims to identify and fast track effective treatments to people with Parkinson’s. The APM will run over five years, with the recruitment for the clinical trial beginning in June 2020.
Please note that if you are experiencing issues submitting the below form, please use this online form instead. Thank you!
For clinicians wanting to register their interest in the APM, use the form below to indicate topics of interest.